Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Cleveland BioLabs, Inc.
Type
Public
Traded as NASDAQ: CBLI
Industry Pharmaceuticals
Founded Cleveland, Ohio, 2003
Headquarters Buffalo, New York, USA
Key people

Yakov Kogan, CEO

Andrei Gudkov, Chief Scientific Officer

Neil Lyons, Chief Financial Officer
Products Anti-radiation and oncological products
Subsidiaries Incuron, LLC
Panacela Labs, Inc.
Website www.cbiolabs.com

Yakov Kogan, CEO

Andrei Gudkov, Chief Scientific Officer

Cleveland BioLabs, Inc. (Nasdaq: CBLI) is a clinical-stage biotechnology company with a focus on oncology development. It specializes in research and development of products with the potential to treat cancer and protect against death following acute radiation syndrome. The company was founded in 2003 and is headquartered in Buffalo, New York. It has license agreements and collaborations with the Cleveland Clinic, Roswell Park Cancer Institute, the Children’s Cancer Institute Australia, and the Armed Forces Radiobiology Research Institute.

Cleveland BioLabs was founded in partnership with the Cleveland Clinic in 2003 and moved to the Buffalo Niagara Medical Campus in 2007.

The following table shows key financial figures for the company for 2011, 2012 and 2013 (parenthesis represent negative figures).

Cleveland Biolabs has two majority-owned subsidiaries:

Investment goal date:
Dividends reinvested
Cleveland BioLabs, Inc. CBLI report Q2 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q4 2017
2018-02-14
--
--
Q3 2017
2017-11-13
--
--
Q2 2017
2017-08-14
0.0000
-0.5000
Q1 2017
2017-05-15
0.0000
-0.1500
Q4 2016
2017-02-22
0.0000
-0.1100
Q3 2016
2016-11-14
0.0000
0.1000
Q2 2016
2016-08-15
0.0000
-0.1700
Q1 2016
2016-05-16
0.0000
-0.0600
Q4 2015
2016-02-22
0.0000
-0.1300
Q3 2015
2015-11-05
0.0000
-0.3100
Q2 2015
2015-08-12
0.0000
-1.1200
Q1 2015
2015-05-06
0.0000
-1.1400
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
BANK OF AMERICA CORP /DE/
100
BLACKROCK ADVISORS LLC
2800
BlackRock Fund Advisors
741
BlackRock Inc.
3541
GEODE CAPITAL MANAGEMENT, LLC
16688
GROUP ONE TRADING, L.P.
68
KCG Holdings, Inc.
13858
LADENBURG THALMANN FINANCIAL SERVICES INC
38680
MORGAN STANLEY
50
RENAISSANCE TECHNOLOGIES LLC
35016
Saiers Capital, LLC
10154
UBS Group AG
100
US BANCORP \DE\
100
Vanguard Group, Inc
82203
Winfield Associates, Inc.
500
Major Shareholders
Name Relationship
Total Shares
Holding stocks
BROWN JULIA R
0.2000% (116482)
BIOD / CBLI / TRGT /
KASTEN BERNARD L
0.0500% (26998)
CBLI / ENZ /
Antal James
0.0100% (8000)
CBLI / SIGA /
Lyons C Neil
0.0400% (20273)
CBLI /
Principi Anthony
0.0900% (52419)
CBLI / EGL / IMMY /
Fonstein Michael
2.0600% (1176465)
CBLI /
DiCorleto Paul E
0.0700% (41968)
CBLI /
Gudkov Andrei V
2.6600% (1517370)
CBLI /
Kogan Yakov
0.0300% (17377)
CBLI /
Perez Hector Daniel
0.0200% (12749)
CBLI /
Hohn David C
0.0800% (43049)
CBLI /
% ()